Key achievements in BBMRI.at #1 were in developing and implementing European and international biobanking standards. The standards served as a reference for harmonizing biobanks in Austria. Further achievements were the development of broadly agreed common MTAs, the building of open source biobanking-related software tools, the cataloguing of samples at Austrian biobanks, establishing a stakeholder engagement platform with the Austrian industry, and the evaluation of citizens? perceptions on biobanking. In the second funding period (BBMRI.at #2, 2018-2023) the operation of Austrian biobanks should be further improved and their sustainability ensured. Major emphasis will be placed on user needs by engagement with different user communities and by continuous monitoring of emerging needs. BBMRI.at will promote the role of quality of biosamples to improve research data reproducibility as prerequisite for reuse and integration of data generated by analysis of biosamples. Therefore, major emphasis will be placed on implementation of biobanking-related standards to fulfil requirements of the new European In-Vitro Diagnostics Regulation. In addition to sample quality, data quality will also be a key topic. Furthermore, existing data management solutions have to be updated to comply with the European General Data Protection Regulation and its national implementation. To improve access to biosamples and data a dedicated work package will be responsible for optimizing and harmonizing access procedures across Austria and in compliance with the BBMRI-ERIC access policy. To increase the visibility of Austrian biobanks and their use, so called ?lighthouse collections? will be established and the implementation of the new biobank at the JKU Linz will be supported. The dynamics of societal expectations in the context of developing science and new legal frameworks will be assessed to provide key input into governance models and the development of a sustainable biobanking strategy.